In This Section
IRB Mission Statement
The Institutional Review Board (IRB) Administration is committed to following the federal regulations to protect the rights and welfare of human subjects involved in research conducted under the auspices of the University of California, Davis.
IRB Compliance Statement
The University of California, Davis, in accordance with its FWA with the Department of Health & Human Services, adheres to all federal and state regulations related to the protection of human research subjects, including 45 CFR 46 (“The Common Rule”), 21 CFR 50, 21 CFR 56 for FDA regulated products, and the principles of The Belmont Report and Institutional policies and procedures. In addition, the International Conference on Harmonization, Good Clinical Practice (ICH GCP) principles are adhered to insofar as they parallel the previously mentioned regulations and policies.
Federalwide Assurance (FWA#): 00004557
FWA Expiration Date: 04/14/2025
UC Davis has adopted a Human Research Protection Program Plan that outlines our responsibility to the UC Davis research community.
The IRB at UC Davis provides not human subjects research, exemption and engagement determinations, well as expedited review and full committee review of non-exempt research. All non-exempt research must comply with applicable federal, state and local requirements to receive IRB approval.
IRB Meeting Dates
The biomedical/clinical committees both meet twice each month. The social and behavioral committee meets monthly.
Meeting Dates: 2017, 2018, 2019, 2020, 2021, 2022, 2023
07/01/13, 01/01/14, 04/18/14, 07/25/14, 08/26/14, 11/18/15, 08/10/16, 10/31/17, 09/07/18, 08/08/19, 11/14/19, 3/10/20, 06/05/20, 06/25/20, 09/23/20, 03/11/21, 07/25/21, 03/07/22